ASCO Conference Coverage
Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.
Treating advanced melanoma patients with either a combination of nivolumab and ipilimumab, or nivolumab alone, significantly increases progression-free survival (PFS) when compared with ipilimumab alone.
Survival gains observed when elotuzumab was added to treatment.
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer.
For some patients with advanced melanoma, surgical removal of the lymph nodes surrounding their tumor may not be needed.
Fewer side effects, longer survival for nivolumab versus docetaxel seen in patients with non-small-cell lung cancer (NSCLC).
Significant clinical variations have been identified among patients with hepatocellular carcinoma (HCC).
A preliminary Australian study saw association between nicotinamide and lower rates of non-melanoma skin cancers.
Researchers report 3 percent annual rise in intermediate- and high-risk cases
When active surveillance is chosen, survival for intermediate-risk disease may be decreased.
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- New Blood Test Improves Screening for Prostate Cancer
- Blood Sample Offers a New Way of Detecting Cancer
- Nanoliposomal Irinotecan Extends Survival in Metastatic Pancreatic Cancer
- Timing Matters for Pegfilgrastim Administration
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- ASH 2015 Placeholder
- Prescription Coverage Impacts Treatment Adherence in Breast Cancer, Even for Low-cost Drugs
- Late-onset Remission Seen in Patients With Lymphoma Treated with Immunomodulatory Drugs
- Impact of Early Palliative Care Varies Depending on Patient Age, Gender
- Weight Gain May Follow Head and Neck Cancer Operations
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|